Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

FMI Small Cap Equity 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (FMI Small Cap Equity)

Primary Source Intelligence • Q3 2024 Letter Analysis

FMI Small Cap Equity Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, FMI Small Cap Equity. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+6.6%

Annualized+13.08%

Digest Analysis

Quick Take

"Added Aramark for defensive growth and margin expansion potential while selling Fabrinet on AI-driven overvaluation."

Executive Summary

FMI Small Cap Equity delivered a solid 6.6% net return in Q3 2024, bringing year-to-date performance to 11.55%. The fund maintains its disciplined value approach, seeking durable business franchises trading at discounts to intrinsic value. The portfolio consists of 30 holdings with strong diversification across sectors, emphasizing companies with recurring revenue streams and attractive returns on invested capital. During the quarter, FMI added Aramark, a food and facilities services leader with defensive characteristics and margin improvement potential driven by market share gains and operational leverage. The firm sold Fabrinet, citing AI-driven market excitement that pushed valuations beyond reasonable levels despite the company's differentiated position. The portfolio trades at reasonable valuations with a forward P/E of 18.1x and maintains high active share at 99%. FMI's long-term investment approach, with typical holding periods of three to five years, continues to focus on fundamental research and business owner mentality in capital allocation decisions.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

Moderate-high conviction evidenced by concentrated 30-stock portfolio with named top 10 holdings and specific position sizes (3.0% Aramark, 1.6% Fabrinet). Detailed fundamental analysis and clear thesis articulation for both purchases and sales demonstrates strong conviction in individual decisions, though diversified approach prevents maximum score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The letter shows mild optimism through selective opportunity identification, particularly in adding Aramark where they see 'signs that the future looks brighter than the past.' However, they also demonstrate caution by selling Fabrinet due to market excitement getting 'ahead of itself,' indicating a balanced but slightly positive market view.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

The portfolio maintains steady positioning with selective additions and sales, showing measured risk appetite. The 30-holding diversified approach and focus on defensive characteristics in new positions like Aramark suggests a cautious but constructive stance rather than aggressive risk-taking.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Modest net deployment activity with one addition (Aramark at 3.0%) and one sale (Fabrinet at 1.6%), resulting in slight net capital deployment. No cash level changes reported, suggesting this represents rotation with modest net addition to equity exposure.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

Forward guidance is limited but shows selective deployment bias. They completed a 3.0% position in Aramark and indicate willingness to re-engage with Fabrinet 'at a lower valuation,' suggesting patient capital deployment rather than aggressive action.

Language Signal

20%

BearishBullish

Bearish (20%)

Language is balanced with selective positive signals. Terms like 'attractive valuation,' 'defensible moat,' and 'long runway' for Aramark are offset by caution around AI excitement and market getting 'ahead of itself' for Fabrinet. Net slightly positive directional language.

Perceived Risk

25%

Low RiskElevated

Low Risk (25%)

Low-moderate risk perception with limited risk discussion. Main risk acknowledgment centers on AI market excitement potentially creating overvaluation in certain names like Fabrinet. Focus on defensive characteristics and recurring revenue suggests awareness of market risks but not heightened concern.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Moderate opportunity density with selective identification of attractive investments. The addition of Aramark suggests available opportunities in defensive names with margin improvement potential, while the sale of Fabrinet indicates selectivity. The focus on market share gains and operational leverage themes suggests a reasonable opportunity set.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Long-term orientation explicitly stated with 'typical holding period for our companies is three to five years' and portfolio turnover of only 20-40% annually. The business owner approach and focus on durable franchises with recurring revenue indicates patient capital with multi-year thesis development.